Navigation Links
Gammapod developed at University of Maryland School of Medicine targets early-stage breast cancer
Date:7/11/2013

breast is fitted into a patented two-layer, vacuum-assisted cup that immobilizes the breast during imaging and treatment. The breast cups come in 28 sizes to provide a proper fit. Such immobilization allows the radiation to strike only the tumor with pinpoint accuracy and minimizes damage to surrounding healthy tissue and adjacent major organs such as the heart and lungs. Treatment will take anywhere from 5-40 minutes, depending on the treatment plan. "We want to make sure the treatment process is as comfortable for women as can be," says Dr. Yu.

"Dr. Yu's accomplishments represent the type of extraordinary innovation and entrepreneurial spirit that we foster here at the School of Medicine," says E. Albert Reece, M.D., Ph.D., M.B.A., Vice President for Medical Affairs at the University of Maryland and John Z. and Akiko K. Bowers Distinguished Professor and Dean of the School of Medicine. "His research is turning groundbreaking discoveries from the laboratory into potentially lifesaving solutions for patients. He is an outstanding research scientist, and we are hopeful that his work will revolutionize the field, changing the way that radiation oncologists approach breast cancer treatment."

Although it has yet to be tested on breast cancer patients, Dr. Yu hopes that the GammaPod will one day offer an alternative to invasive surgery in those with early-stage tumors. "With standard therapy, breast cancer patients often have surgery to remove the tumor, followed by five to seven weeks of radiation treatments to destroy any residual cancer cells," says Dr. Yu. "We hope that GammaPod will dramatically reduce the treatment time to a few treatments that can be done over the course of a week. There is potential that the need for surgery could be eliminated altogether, meaning no needles, no knives, no anesthesia and no scars."

Clinical trials are a critical next step to bringing the GammaPod to patients. Principal investigator on the trials at the
'/>"/>

Contact: Karen Robinson
karobinson@som.umaryland.edu
410-706-7590
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Geographic Information Systems aid health research in developed and developing countries
2. First Ever Over-the-Counter Organic Anti-Itch Ointment Developed by US Organic Group Corp.
3. Universities.com Recognizes Newly Developed Health Care Degree Programs as the Industry Continues to Grow
4. Mobile health app developed at UCLA simplifies process of choosing birth control method
5. hCGTreatments / Diet Doc hCG Diets and Weight Loss Plans Announce New, Uniquely Developed Diet Meal Plans That Take the Guesswork Out of Mealtime Preparation
6. US Drug Watchdog Now Urges Transvaginal Failure Victims To Call Them For The Contacts Of National Caliber Women Lawyers If They Have Developed Severe Complications
7. US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure Who Have Developed Severe Complications To Call Them For The Names Of Top Women Lawyers In The Nation
8. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
9. Food safety and bioterrorism defense may benefit from improved detection test developed at MU
10. New drug combination therapy developed to treat leukemia
11. Complete H2O Minerals Has Developed a Product for Women Using the Benefits of Liquid Vitamins and Minerals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 From November 24, 2014, ... for the year 2014 in its Goa retreat . ... Through the Indian winters, from November to March, Siddhi Yoga ... beach of Arambol, Goa. The Goa training sessions will conclude ... of yoga teacher training, the 10th intake is also a ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... Randy Dotinga ... News) -- Common painkillers, including ibuprofen, might slightly reduce ... researchers say. Use of ibuprofen (Advil, Motrin) and ... cell skin cancer by 15 percent, the researchers concluded ... is usually caused by sun exposure. ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Dr. Myo Nwe ... Weight Loss Diet of the Future” and co-founder of the ... her book, Dr. Nwe takes a broad look at the ... hold up under scientific scrutiny. On film and in television ... emphasized mostly toward the social aspects and played for basic ...
(Date:12/17/2014)... In its comprehensive analysis of medical ... Claim Review division have recently identified out-of-network and medical ... savings are achieved on behalf of employer-clients. , ... in savings to Argus each year, with a total ... by Tom Doney, Cypress president and CEO, these in-depth ...
Breaking Medicine News(10 mins):Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2
... Ready or not, the holiday season,is here. The ... and pies, merry-making eggnog and potato latkes,and then New ... Super Bowl,buffalo wings and Valentine,s Day chocolates to contend ... holiday cooking and,feasting., Enter Helene Phillips, the mind, ...
... TeamHealth Inc.,s parent,company, Team Finance LLC (the "Company") ... 30, 2008., The Company previously announced the ... and substantially completed the disposal,of this business line ... with,relevant accounting guidance, the results of the anesthesia ...
... Of $9 million appropriated by,the Texas legislature ... of automated external defibrillators (AEDs), $3.5 million remains,unclaimed. ... AED purchase under,the reimbursement program until the November ... used by lay people with CPR training,to resuscitate ...
... analysis of 33 research projects , , MONDAY, Nov. 10 (HealthDay ... as beta blockers has concluded that they are not useful ... using beta blockers for non-coronary surgery may actually increase the ... conducted the study -- known as a meta-analysis -- recommend ...
... Primary Care Physician Recruitment, ORLANDO, Fla., Nov. 10 ... shortage - with primary care,being especially hard hit. As ... this shortage promises to get worse with major,repercussions for ... is working to address this issue with a new ...
... with Top-Ranked ... ... social,network for physicians practicing in the U.S., is hosting a ... of the causes and consequences of the current,economic downturn and ...
Cached Medicine News:Health News:Tips for Maintaining Your Physique While Enjoying Your Favorite Treats 2Health News:Tips for Maintaining Your Physique While Enjoying Your Favorite Treats 3Health News:Team Finance LLC Announces Third Quarter 2008 Results 2Health News:Team Finance LLC Announces Third Quarter 2008 Results 3Health News:Team Finance LLC Announces Third Quarter 2008 Results 4Health News:Team Finance LLC Announces Third Quarter 2008 Results 5Health News:Team Finance LLC Announces Third Quarter 2008 Results 6Health News:Team Finance LLC Announces Third Quarter 2008 Results 7Health News:Team Finance LLC Announces Third Quarter 2008 Results 8Health News:Team Finance LLC Announces Third Quarter 2008 Results 9Health News:$3.5 Million in Reimbursements for Purchases of Automated External Defibrillators (AEDs) for Texas Schools Still Unclaimed With Deadline Approaching 2Health News:Beta Blocker Use Questioned in Non-Heart Surgery 2Health News:Beta Blocker Use Questioned in Non-Heart Surgery 3Health News:AMA Works to Reverse Primary Care Physician Shortage 2Health News:iMedExchange Responses to Financial Crisis 2
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... (NASDAQ: VOLC ), a global leader in catheter-based ... they have entered into a definitive merger agreement. Pursuant to ... all of the issued and outstanding shares of Volcano for ... of USD 1 billion (approx. EUR 800 million), to be ...
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: